← Back to Search

Neural Imaging for Patellofemoral Pain Syndrome

N/A

Waitlist Available

Led By Gregory D Myer, PhD

Research Sponsored by Children's Hospital Medical Center, Cincinnati

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1 (during mri session)

Awards & highlights

Study Summary

This trial looks at how knee pain affects movement in young women.

Eligible Conditions

Patellofemoral Pain Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1 (during mri session)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1 (during mri session)

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (during mri session) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Blood Oxygen Level Dependent (BOLD) Signal During Flexion/Extension Movement

Blood Oxygen Level Dependent (BOLD) Signal During Pain Inducing Tasks

Blood Oxygen Level Dependent (BOLD) Signal During Quadriceps Contraction

+1 more

Secondary outcome measures

Knee

Pain Scale Score

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Neural ImagingExperimental Treatment1 Intervention

Females with PFP attending a single study visit where neural imaging is acquired via MRI.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor

815 Previous Clinical Trials

6,531,581 Total Patients Enrolled

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,560,558 Total Patients Enrolled

1 Trials studying Patellofemoral Pain Syndrome

34 Patients Enrolled for Patellofemoral Pain Syndrome

Gregory D Myer, PhDPrincipal InvestigatorEmory University

16 Previous Clinical Trials

2,718 Total Patients Enrolled

Media Library

Neural Imaging Clinical Trial Eligibility Overview. Trial Name: NCT04099004 — N/A

Patellofemoral Pain Syndrome Research Study Groups: Neural Imaging

Patellofemoral Pain Syndrome Clinical Trial 2023: Neural Imaging Highlights & Side Effects. Trial Name: NCT04099004 — N/A

Neural Imaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT04099004 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for participants to enroll in this experiment currently?

"Affirmative, according to the information provided by clinicaltrials.gov, this research endeavour is currently recruiting participants. It was initially advertised on November 16th 2017 and revised for the last time October 21st 2022. Two sites are enrolling a total of 30 individuals in the trial."

Answered by AI

Does this research program take participants who are over the age of sixty?

"Eligibility for this research is limited to those aged between 7 and 40. In comparison, there are 378 studies that accept minors and 997 clinical trials available to seniors."

Answered by AI

What is the scope of participants in this medical experiment?

"Affirmative. Clinicaltrials.gov's records demonstrate that this investigation is presently pursuing participants, having first been posted on November 16th 2017 and last updated October 21st 2022. The trial requires 30 individuals to be recruited from 2 distinct research centres."

Answered by AI

Do I meet the necessary criteria to partake in this research trial?

"This research study is open to 30 individuals aged 7-40 who suffer from patellofemoral pain. Most crucially, all applicants must be able to provide written consent."

Answered by AI

What are the major goals of this medical experiment?

"The primary assessment of this two-year trial will be the Blood Oxygen Level Dependent (BOLD) Signal During Flexion/Extension Movement. Other secondary outcomes to track are scores from the International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Anterior Knee pain Scale (AKPS), and IKDC Questionnaire - all three measuring levels of perceived knee pain, function and disability."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Neural Correlates of Knee Sensorimotor Control in Patients With Patellofemoral Pain Syndrome

Greg Myer 2017. "Neural Correlates of Knee Sensorimotor Control in Patients With Patellofemoral Pain Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04099004.